Bydureon (by-DUR-ee-on), the new long-acting form of Byetta (exenatide) for type 2 diabetes
You'll see Bydureon (by-DUR-ee-on), the new long-acting form of Byetta (exenatide) for type 2 diabetes.
Bydureon is injected just once a WEEK...compared to twice a day for Byetta or once a day for Victoza (liraglutide).
It sometimes makes sense to add these glucagon-like peptide-1 (GLP-1) agonists to oral meds to improve glycemic control and help patients lose weight.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote